Keyword Connections

Rivaroxaban

Journals

9

1 PloS one

2 european journal of endocrinology

3 jornal vascular brasileiro

4 Clinical cardiology

5 the western journal of emergency medicine

6 american journal of clinical oncology

7 cancer

8 diabetic medicine : a journal of the british diabetic association

9 high blood pressure & cardiovascular prevention : the official journal of the italian society of hypertension

Research Groups

0

No Research Group Connected

Bibliographies

27

1 Effect of CYP3A4, CYP3A5, ABCB1 Gene Polymorphisms on Rivaroxaban Pharmacokinetics in Patients Undergoing Total Hip and Knee Replacement Surgery.

2 Cost-effectiveness analysis of low-dose direct oral anticoagulant (DOAC) for the prevention of cancer-associated thrombosis in the United States.

3 Associations of area deprivation and urban/rural traits with the incidence of type 1 diabetes: analysis at the municipality level in North Rhine-Westphalia, Germany.

4 Does prolonged television viewing affect Body Mass Index? A case of the Kingdom of Saudi Arabia.

5 Social determinants of food group consumption based on Mediterranean diet pyramid: A cross-sectional study of university students.

6 Bayesian multiple membership multiple classification logistic regression model on student performance with random effects in university instructors and majors.

7 Prospective evaluation of autoimmune and non-autoimmune subclinical hypothyroidism in Down syndrome children.

8 rivaroxaban versus low weight heparins for venous thromboembolism prophylaxis after major hip and knee arthroplasty: systematic review and metaanalysis = rivaroxaban frente a heparinas de bajo peso molecular para la prevención de la tromboembolia venosa posterior al reemplazo total de cadera o rodilla: revisión sistemática de la literatura y metaanálisisis

9 crystal structure of (s)-5-chloro-n-({2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]oxazolidin-5-yl}methyl)thiophene-2-carboxamide

10 the new oral anticoagulants for the treatment of venous thromboembolism: a new paradigm shift in antithrombotic therapy

11 use of direct oral anticoagulants for the prevention and treatment of thromboembolic disease in patients with reduced renal function: a short review of the clinical evidence

12 Analysis of recanalization of deep venous thrombosis: a comparative study of patients treated with warfarin vs. rivaroxaban.

13 Initial rivaroxaban dosing in patients with atrial fibrillation.

14 Impact of rivaroxaban on stent thrombosis and secondary prevention of cardiovascular events in acute coronary syndrome

15 Successful Resolution of a Large Left Atrial and Left Atrial Appendage Thrombus with Rivaroxaban

16 Impact of rivaroxaban on stent thrombosis and secondary prevention of cardiovascular events in acute coronary syndrome

17 Comparative effectiveness of warfarin, dabigatran, rivaroxaban and apixaban in non-valvular atrial fibrillation: A nationwide pharmacoepidemiological study.

18 Rivaroxaban versus warfarin treatment among morbidly obese patients with venous thromboembolism: Comparative effectiveness, safety, and costs.

19 Association Between Low-Dose Rivaroxaban With or Without Aspirin and Ischemic Stroke Subtypes: A Secondary Analysis of the COMPASS Trial.

20 Investigation of the profile and kinetics of degradation of rivaroxaban using HPLC, TLC-densitometry and LC/MS/MS: Application to pre-formulation studies

21 Ozonation of rivaroxaban production waste water and comparison of generated transformation products with known in vivo and in vitro metabolites.

22 An evaluation of rivaroxaban and clopidogrel in a rat lower extremity ischemia-reperfusion model: An experimental study.

23 clinical utility of rivaroxaban in stroke prevention associated with nonvalvular atrial fibrillation – patient considerations

24 rivaroxaban treatment for warfarin-refractory thrombosis in a patient with hereditary protein s deficiency

25 treatment application of rivaroxaban in chinese patients with livedoid vasculopathy

26 prevention of thromboembolic complications in atrial fibrillation - rat poison or new oral anticoagulants: do we have a choice, and should we be afraid to make it? first clinical experience with rivaroxaban in nizhny novgorod

27 Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source.